相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects
Peng Huang et al.
NEUROPHARMACOLOGY (2022)
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus
Steven Fishbane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Characterization of a Knock-In Mouse Line Expressing a Fusion Protein of κ Opioid Receptor Conjugated with tdTomato: 3-Dimensional Brain Imaging via CLARITY
Chongguang Chen et al.
ENEURO (2020)
Comparison of Pharmacological Properties between the Kappa Opioid Receptor Agonist Nalfurafine and 42B, Its 3-Dehydroxy Analogue: Disconnect between in Vitro Agonist Bias and in Vivo Pharmacological Effects
Danni Cao et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Pharmacological and phosphoproteomic approaches to roles of protein kinase C in kappa opioid receptor-mediated effects in mice
Jeffrey J. Liu et al.
NEUROPHARMACOLOGY (2020)
Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion
Jeffrey J. Liu et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses
Amelia D. Dunn et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
Shane W. Kaski et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor
Selena S. Schattauer et al.
CELLULAR SIGNALLING (2017)
Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization
Chongguang Chen et al.
BIOCHEMICAL JOURNAL (2016)
Biased agonism: An emerging paradigm in GPCR drug discovery
Zoran Rankovic et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Intrinsic relative activities of κ opioid agonists in activating Gα proteins and internalizing receptor: Differences between human and mouse receptors
Kelly M. DiMattio et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons
Jonathan M. Ehrich et al.
JOURNAL OF NEUROSCIENCE (2015)
Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus
Jenny Morgenweck et al.
NEUROPHARMACOLOGY (2015)
The G Protein-Biased kappa-Opioid Receptor Agonist RB-64 Is Analgesic with a Unique Spectrum of Activities In Vivo
Kate L. White et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Fulfilling the Promise of Biased G Protein-Coupled Receptor Agonism
Louis M. Luttrell et al.
MOLECULAR PHARMACOLOGY (2015)
Essential Structure of the κ Opioid Receptor Agonist Nalfurafine for Binding to the κ Receptor
Hiroshi Nagase et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Identification of Novel Functionally Selective κ-Opioid Receptor Scaffolds
Kate L. White et al.
MOLECULAR PHARMACOLOGY (2014)
Functional Selectivity of 6′-Guanidinonaltrindole (6′-GNTI) at κ-Opioid Receptors in Striatal Neurons
Cullen L. Schmid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors
Lei Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
OPINION Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Terry Kenakin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects
Katherine A. MacLean et al.
PSYCHOPHARMACOLOGY (2013)
Selective p38α MAPK Deletion in Serotonergic Neurons Produces Stress Resilience in Models of Depression and Addiction
Michael R. Bruchas et al.
NEURON (2011)
Ligand-Directed Trafficking of the δ-Opioid Receptor In Vivo: Two Paths Toward Analgesic Tolerance
Amynah A. A. Pradhan et al.
JOURNAL OF NEUROSCIENCE (2010)
Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study
Hiroo Kumagai et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Kinase cascades and ligand-directed signaling at the kappa opioid receptor
Michael R. Bruchas et al.
PSYCHOPHARMACOLOGY (2010)
In Vivo Delta Opioid Receptor Internalization Controls Behavioral Effects of Agonists
Amynah A. A. Pradhan et al.
PLOS ONE (2009)
2-methoxymethyl-salvinorin B is a potent κ opioid receptor agonist with longer lasting action in vivo than salvinorin A
Yulin Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Stress-induced p38 mitogen-activated protein kinase activation mediates κ-opioid-dependent dysphoria
Michael R. Bruchas et al.
JOURNAL OF NEUROSCIENCE (2007)
Estimation of agonist activity at G protein-coupled receptors:: Analysis of M2 muscarinic receptor signaling through Gi/o, Gs, and G15
Michael T. Griffin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance
JP McLaughlin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Agonist-induced regulation and trafficking of κ opioid receptors
LY Liu-Chen
LIFE SCIENCES (2004)
Salvinorin A:: A potent naturally occurring nonnitrogenous κ opioid selective agonist
BL Roth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans
SL Walsh et al.
PSYCHOPHARMACOLOGY (2001)
分享论文
